Skip to content

Gene expression test for diagnosis in tuberculous pleuritis

Gene expression test for diagnosis in tuberculous pleuritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190204003
Enrollment
Unknown
Registered
2019-02-04
Start date
2018-11-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The differential diagnosis between the TB pleuritis and the malignant pleural effusion (MPE) is difficult because the clinical manifestations are the same. the accurate diagnostic test are important. gene expression tuberculous pleuritis malignant pleural effusion

Interventions

malignant pleural effusion group&#44
meet all inclusion criteria (1) age not less than 18 years old (2) lymphocyte predominated exudative pleural effusion (3) no contraindication to pleural tapping and biopsy (4) sign informed consent b
any of the two following (1) PCR&#45
TB from the pleural fluid or pleural tissue or sputum report the mycobacterioum tuberculosis organism (2) Mycobacterial culture from the pleural fluid or pleural tissue or sputum report the mycobacte
any of the following (1) the pathology from the pleural biopsy report the granulomatous pleuritis and the patient&#39
s clinical symptoms improve from the tuberculosis treatment (2) The acid fast bacilli staining from the pleural fluid or pleural tissue or sputum report positive and the patient&#39
s clinical symptoms improve from the tuberculosis treatment 3) Probable diagnosis is the finding of the lymphocyte predominated exudative pleural effusion and the patient&#39
s clinical symptoms improve from the tuberculosis treatment
Diagnostic,Diagnostic
control group,study group or case group

Sponsors

Ratchadapiseksompotch Research Fund
Lead Sponsor
Department of Medical Sciences&#44
Collaborator
Ministry of Public Health&#44
Collaborator
Thailand
Collaborator

Eligibility

Sex/Gender
All
Age
1 Years to 2 Years

Inclusion criteria

Inclusion criteria: 1. Age not less than 18 year-old 2. The mononuclear cell predominated exudative pleural effusion 3. The subjects display voluntary for thoracocentesis, pleural biopsy and finally receiving the diagnostic result of TB pleuritis (case group) or malignant pleural effusion (control group) 4. The subjects sign consent form before the data collection

Exclusion criteria

Exclusion criteria: 1. The subjects have any contraindication to the invasive procedure, such as bleeding disorder. 2. The polymorphonuclear cell predominated exudative pleural effusion 3. The unknown of the final diagnostic result of pleural effusion

Design outcomes

Primary

MeasureTime frame
The level of each gene expression (copies/micro-lite) immediate after enrollment or within 2 weeks if the patient, who diagnosed as the TB pleuritis, rece Droplet digital PCR (copies/micro-lite)

Secondary

MeasureTime frame
contraceptive implant removal duration From the start to the end of the procedure Record time in second ,Success rate Immediate after the entire contraceptive rod is removed Success or failure,Satisfaction Immediate after contraceptive implant removal procedure 5 point Likert scale ,Side effect of anesthesia after applying the anesthesia(Ethyl chloride spray or lidocaine Record side effect of anesthesia

Contacts

Public ContactKamon Kawkitinarong

Faculty of Medicine, Chulalongkorn University, Thailand

kamonkaw@hotmail.com66813111501

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026